Dataset Information
A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS
Ontology highlight
ABSTRACT:
SUBMITTER: Searle E
PROVIDER: S-EPMC12379018 | biostudies-literature | 2025 Jul
REPOSITORIES: biostudies-literature